Larysa Baraban

Prof. Larysa Baraban leads the Life Science Nanomicrosystems department at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR), focusing on advanced biosensor technologies and nanomedicine. Her research integrates nanoelectronics, microfluidics, and immunotherapy to develop innovative diagnostic and therapeutic tools for cancer and infectious diseases.

• Key Projects: CAR T-cell monitoring platforms, plasmonic nanoparticle therapies, and droplet-based diagnostic systems.
• Expertise: Nanobiosensors, active matter dynamics, and lab-on-a-chip systems.

Her work bridges physics and medicine, with recent breakthroughs in real-time drug monitoring and tumor heterogeneity analysis. Collaborations include HZDR's Radio pharmaceutical Cancer Research Institute and international organizations.

Publications highlight advancements in nanomaterials for hyperthermia therapy, SARS-CoV-2 neutralization strategies, and 3D tumor models for immunotherapy evaluation.